Industry News

1 1

Eight Chinese pharma firms may be blacklisted over quality issues

NEW DELHI: The Indian government has issued showcause notices to, and may soon blacklist, eight Chinese pharmaceutical companies found to be supplying poor quality raw material to drug manufacturers in this country.  The notices were issued after a special inspection team of the Drug Con...

Read More

2 2

China accounts for 66 per cent of India's bulk drug imports in FY17

NEW DELHI: India's bulk drug imports from top five countries stood at Rs 18,372.54 crore in 2016-17 with China accounting for 66 per cent, Parliament was informed today.  In a written reply in Lok Sabha, Minister of State, Chemicals and Fertilisers Mansukh L Mandaviya said the other ...

Read More

3 3

DCGI mulls alternatives to China active pharmaceutical ingredients

MUMBAI: The Drug Controller General of India (DCGI) has got local drugmakers to draw up an emergency plan on dealing with any blockade on shipments from China of active pharmaceutical ingredients (APIs), or raw materials used to make medicines, in the event of border tensions escalating. Indian c...

Read More

4 4

Italian firm Olon buys Ricerca Biosciences' chemical division

Olon SpA, the Italy-based active pharmaceutical ingredients (API) contract development and manufacturing organisation (CDMO) and generics supplier, has acquired Ricerca Biosciences’ chemical division of the contract research (CRO) and CDMO based in Concord, Ohio (USA). T...

Read More